Revenue
2021
2022
2023
2024
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | N/A | £368.5M | £364.4M | £344.3M | £311.1M |
| Operating expenses | N/A | £105.6M | £96.2M | £88.2M | £75.3M |
| Operating income | N/A | £32.8M | £20.8M | £30.6M | £55.6M |
| Operating margin | N/A | 8.90% | 5.71% | 8.89% | 17.87% |
| EBITDA | N/A | £45.7M | £30.8M | £37.2M | £60.6M |
| EBITDA margin | N/A | 12.40% | 8.45% | 10.80% | 19.48% |
| Net income | N/A | £24.4M | £15.4M | £24.9M | £44.6M |
| Net profit margin | N/A | 6.62% | 4.23% | 7.23% | 14.34% |
| Basic EPSper basic share | £0.19 | £0.21 | £0.13 | £0.21 | N/A |
| Diluted EPSper diluted share | £0.19 | £0.21 | £0.13 | £0.21 | N/A |
Reported major voting-rights holders
| Holder | Voting rights |
|---|---|
| 9.06%Aug 1, 2025 · 10.86M votes | |
| 1.64%Sep 21, 2026 · 1.83M votes |
These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.
Gray completes the 100% scale; it is not an estimate of other owners.
Fever-Tree ($FEVR) reported adjusted brand revenue of £183.6 million in the first half, an 8% increase at constant exchange rates. US revenue grew 11% on the same basis as its Molson Coors partnership gained momentum, while the UK returned ...